Duncan Jason
Neumora Therapeutics, Inc. Common Stock · See Remarks
Duncan Jason is listed in public filings as officer: See Remarks. This Duncan Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neumora Therapeutics, Inc. Common Stock (NMRA). Investors use Duncan Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.7M750k shares | Grant / ExerciseJan 8, 2026 | $1.7M750k shares | $2.33 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0500k shares | OtherMay 28, 2025 | $845.0K500k shares | $1.69 | -- | |
| $360k500k shares | Grant / ExerciseMay 28, 2025 | $360.0K500k shares | $0.72 | -- | |
| $288k400k shares | Grant / ExerciseMay 28, 2025 | $288.0K400k shares | $0.72 | -- | |
| $0400k shares | OtherFeb 13, 2025 | $5.2M400k shares | $12.97 | -- | |
| $845k500k shares | Grant / ExerciseFeb 13, 2025 | $845.0K500k shares | $1.69 | -- | |
| $676k400k shares | Grant / ExerciseFeb 13, 2025 | $676.0K400k shares | $1.69 | -- |